Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Latest Information Update: 17 Aug 2024
At a glance
- Drugs Hydroxychloroquine (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 Aug 2024 Planned End Date changed from 1 Mar 2025 to 1 Jun 2025.
- 13 Aug 2024 Planned primary completion date changed from 1 Mar 2024 to 1 Jun 2025.
- 13 Aug 2024 Status changed from recruiting to active, no longer recruiting.